Safety and Effectiveness Investigation for Dry, Non-Exudative Age Related Macular Degeneration (AMD) Using Rheopheresis

NCT00460967 · clinicaltrials.gov ↗
PHASE3
Phase
SUSPENDED
Status
325
Enrollment
INDUSTRY
Sponsor class

Stopped In light of the company's current financial position we have indefinately suspended the Rheo-AMD trial.

Conditions

Interventions

Sponsor

OccuLogix